Direct renin inhibitors US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Direct renin inhibitors. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Direct renin inhibitors US Medical PG Question 1: A 38-year-old man presents to his physician with recurrent episodes of facial swelling and abdominal pain. He reports that these episodes started when he was approximately 16 years of age. His mother also has similar episodes of swelling accompanied by swelling of her extremities. The vital signs include: blood pressure 140/80 mm Hg, heart rate 74/min, respiratory rate 17/min, and temperature 36.6℃ (97.8℉). His physical examination is unremarkable. The laboratory work-up shows the following findings:
Test Result Normal range
C1 esterase inhibitor 22% > 60%
Complement C4 level 9 mg/dL 14–40 mg/dL
Complement C2 level 0.8 mg/dL 1.1–3.0 mg/dL
Complement component 1q 17 mg/dL 12–22 mg/dL
Which of the following anti-hypertensive medications is contraindicated in this patient?
- A. Amlodipine
- B. Fosinopril (Correct Answer)
- C. Atenolol
- D. Indapamide
- E. Valsartan
Direct renin inhibitors Explanation: ***Fosinopril***
- This patient presents with symptoms and lab findings consistent with **hereditary angioedema (HAE)**, characterized by recurrent episodes of **facial swelling** and **abdominal pain**, low C1 esterase inhibitor, and low C4/C2 levels. **ACE inhibitors** like fosinopril are absolutely **contraindicated in HAE** because they can trigger life-threatening angioedema attacks by increasing bradykinin levels.
- The family history of similar swelling further supports the diagnosis of HAE, making any medication that exacerbates bradykinin a significant risk.
*Amlodipine*
- **Dihydropyridine calcium channel blockers** such as amlodipine are generally considered safe in patients with angioedema and do not interfere with the bradykinin pathway.
- They are a suitable option for hypertension management in these patients.
*Atenolol*
- **Beta-blockers** like atenolol are generally safe for managing hypertension in patients with a history of angioedema, as they do not affect the complement or bradykinin systems.
- There is no evidence to suggest that atenolol would worsen angioedema symptoms.
*Indapamide*
- **Thiazide diuretics** such as indapamide are safe and effective antihypertensive agents in patients with angioedema.
- They work by increasing sodium and water excretion and do not interact with the pathways involved in angioedema.
*Valsartan*
- **Angiotensin receptor blockers (ARBs)** like valsartan are generally considered safer than ACE inhibitors in patients with angioedema, although a small risk of angioedema still exists due to their weak effect on bradykinin.
- However, the primary family of drugs to avoid in HAE is ACE inhibitors due to their direct and significant impact on bradykinin degradation.
Direct renin inhibitors US Medical PG Question 2: A 75 year-old gentleman presents to his general practitioner. He is currently being treated for hypertension and is on a multi-drug regimen. His current blood pressure is 180/100. The physician would like to begin treatment with minoxidil or hydralazine. Which of the following side effects is associated with administration of these drugs?
- A. Persistent cough
- B. Cyanosis in extremities
- C. Fetal renal toxicity
- D. Systemic volume loss
- E. Reflex tachycardia (Correct Answer)
Direct renin inhibitors Explanation: ***Reflex tachycardia***
- Both **minoxidil** and **hydralazine** are direct arterial vasodilators, causing a significant drop in **peripheral vascular resistance**.
- This vasodilation triggers a **baroreflex response**, leading to an increase in heart rate and **cardiac contractility** to maintain cardiac output, resulting in reflex tachycardia.
*Persistent cough*
- **Persistent cough** is a common side effect associated with **ACE inhibitors**, such as lisinopril or enalapril, due to the accumulation of **bradykinin**.
- This side effect is not typically seen with **minoxidil** or **hydralazine**, which act directly on vascular smooth muscle to cause vasodilation.
*Cyanosis in extremities*
- **Cyanosis** (bluish discoloration of the skin and mucous membranes) usually indicates **hypoxemia** or poor peripheral perfusion.
- While sometimes associated with severe cardiogenic shock or specific drug toxicities like methemoglobinemia (not related to minoxidil or hydralazine), it is not a direct or typical side effect of these vasodilators.
*Fetal renal toxicity*
- **Fetal renal toxicity**, including **fetal renal dysfunction** and **oligohydramnios**, is a well-known risk associated with **ACE inhibitors** and **ARBs** during pregnancy.
- Neither **minoxidil** nor **hydralazine** are primarily linked to this specific fetal adverse effect, though hydralazine can be used in pregnancy for severe hypertension.
*Systemic volume loss*
- **Systemic volume loss** is usually caused by conditions like **dehydration**, excessive diuresis, or hemorrhage.
- While vasodilators can reduce blood pressure, they do not directly cause **systemic volume depletion**; rather, the reflex response to vasodilation can include fluid retention to counteract the blood pressure drop.
Direct renin inhibitors US Medical PG Question 3: A patient presents with periods of severe headaches and flushing however every time they have come to the physician they have not experienced any symptoms. The only abnormal finding is a blood pressure of 175 mmHg/100 mmHg. It is determined that the optimal treatment for this patient is surgical. Prior to surgery which of the following noncompetitive inhibitors should be administered?
- A. Phentolamine
- B. Isoproterenol
- C. Atropine
- D. Propranolol
- E. Phenoxybenzamine (Correct Answer)
Direct renin inhibitors Explanation: ***Phenoxybenzamine***
- This patient likely has a **pheochromocytoma**, which explains the episodic headaches, flushing, and hypertension. **Phenoxybenzamine** is a **non-competitive, irreversible alpha-adrenergic blocker** that is crucial for preoperative preparation to prevent a **hypertensive crisis** during surgery.
- Its **irreversible binding** provides sustained alpha blockade, essential to control blood pressure and avoid catecholamine-induced surges during tumor manipulation.
*Phentolamine*
- **Phentolamine** is a **competitive alpha-adrenergic blocker** used to manage acute hypertensive episodes, but it has a shorter duration of action.
- It is not preferred for sustained preoperative alpha blockade due to its **reversible nature** and potential for drug washout during surgery, which could lead to catecholamine surges.
*Isoproterenol*
- **Isoproterenol** is a **beta-adrenergic agonist** that increases heart rate and contractility, and causes bronchodilation.
- It would be contraindicated in a patient with pheochromocytoma as it could worsen hypertension and cardiac symptoms by stimulating beta receptors that are already overly sensitive to endogenous catecholamines.
*Atropine*
- **Atropine** is a **muscarinic acetylcholine receptor antagonist** that blocks parasympathetic effects, like bradycardia and salivation.
- It has no role in managing hypertension or the catecholamine excess seen in pheochromocytoma.
*Propranolol*
- **Propranolol** is a **non-selective beta-adrenergic blocker** that can be used to control tachycardia and arrhythmias in pheochromocytoma, but only *after* adequate alpha-blockade has been established.
- Using **propranolol alone** or before alpha-blockade can lead to **unopposed alpha-adrenergic stimulation**, resulting in a severe, life-threatening hypertensive crisis.
Direct renin inhibitors US Medical PG Question 4: A 59-year-old man with a history of congestive heart failure presents to his cardiologist for a follow-up visit. His past medical history is notable for diabetes mellitus, hypertension, and obesity. He takes metformin, glyburide, aspirin, lisinopril, and metoprolol. He has a 40 pack-year smoking history and drinks alcohol socially. His temperature is 99.1°F (37.2°C), blood pressure is 150/65 mmHg, pulse is 75/min, and respirations are 20/min. Physical examination reveals bilateral rales at the lung bases and 1+ edema in the bilateral legs. The physician decides to start the patient on an additional diuretic but warns the patient about an increased risk of breast enlargement. Which of the following is the most immediate physiologic effect of the medication in question?
- A. Decreased sodium reabsorption in the distal convoluted tubule
- B. Decreased bicarbonate reabsorption in the proximal convoluted tubule
- C. Decreased sodium reabsorption in the thick ascending limb
- D. Decreased renin enzyme activity
- E. Decreased sodium reabsorption in the collecting duct (Correct Answer)
Direct renin inhibitors Explanation: ***Decreased sodium reabsorption in the collecting duct***
- The physician is initiating **spironolactone**, an **aldosterone antagonist**, due to its known side effect of **gynecomastia** (breast enlargement).
- Spironolactone acts on the **collecting duct** to inhibit aldosterone's effects, leading to decreased sodium reabsorption and **decreased potassium excretion** (potassium-sparing effect).
- This makes it useful in heart failure but requires monitoring for **hyperkalemia**, especially in patients on ACE inhibitors like lisinopril.
*Decreased sodium reabsorption in the distal convoluted tubule*
- This is the primary site of action for **thiazide diuretics**, such as **hydrochlorothiazide** or **chlorthalidone**.
- While effective for heart failure, thiazides are not associated with breast enlargement.
*Decreased bicarbonate reabsorption in the proximal convoluted tubule*
- This is the main action of **carbonic anhydrase inhibitors**, such as **acetazolamide**.
- These diuretics are typically used for conditions like glaucoma or metabolic alkalosis, not first-line for heart failure and do not cause breast enlargement.
*Decreased sodium reabsorption in the thick ascending limb*
- This is the mechanism of action for **loop diuretics**, such as **furosemide** or **bumetanide**.
- Loop diuretics are potent and frequently used in heart failure, but they do not cause breast enlargement.
*Decreased renin enzyme activity*
- This effect is primarily seen with **beta-blockers** or **direct renin inhibitors**.
- While beta-blockers (like metoprolol, which the patient is already taking) are used in heart failure, they do not cause breast enlargement.
Direct renin inhibitors US Medical PG Question 5: A new drug X is being tested for its effect on renal function. During the experiments, the researchers found that in patients taking substance X, the urinary concentration of sodium decreases while urine potassium concentration increase. Which of the following affects the kidneys in the same way as does substance X?
- A. Aldosterone (Correct Answer)
- B. Furosemide
- C. Spironolactone
- D. Atrial natriuretic peptide
- E. Hydrochlorothiazide
Direct renin inhibitors Explanation: ***Aldosterone***
- **Aldosterone** acts on the **principal cells** of the **collecting duct** to increase sodium reabsorption and potassium secretion.
- This action leads to a decrease in urinary sodium concentration and an increase in urinary potassium concentration, matching the effects of drug X.
*Furosemide*
- **Furosemide** is a **loop diuretic** that inhibits the **Na-K-2Cl cotransporter** in the **thick ascending limb** of the loop of Henle.
- This inhibition leads to increased excretion of sodium, potassium, and water, resulting in higher urinary sodium concentration.
*Spironolactone*
- **Spironolactone** is an **aldosterone antagonist** that blocks aldosterone's effects on the collecting duct.
- This leads to increased sodium excretion and decreased potassium excretion (potassium-sparing effect), which is the opposite of drug X.
*Atrial natriuretic peptide*
- **Atrial natriuretic peptide (ANP)** is released in response to atrial stretch and causes **natriuresis** (increased sodium excretion) and **diuresis**.
- It works by dilating afferent arterioles and constricting efferent arterioles, increasing GFR, and inhibiting sodium reabsorption, thus increasing urinary sodium concentration.
*Hydrochlorothiazide*
- **Hydrochlorothiazide** is a **thiazide diuretic** that inhibits the **Na-Cl cotransporter** in the **distal convoluted tubule**.
- This leads to increased sodium and chloride excretion but typically causes potassium wasting (hypokalemia), which differs from the increased urinary potassium concentration seen with drug X.
Direct renin inhibitors US Medical PG Question 6: A 57-year-old otherwise healthy male presents to his primary care physician for a check-up. He has no complaints. His blood pressure at the previous visit was 160/95. The patient did not wish to be on any medications and at the time attempted to manage his blood pressure with diet and exercise. On repeat measurement of blood pressure today, the reading is 163/92. His physician decides to prescribe a medication which the patient agrees to take. The patient calls his physician 6 days later complaining of a persistent cough, but otherwise states that his BP was measured as 145/85 at a local pharmacy. Which of the following is a contraindication to this medication?
- A. Congestive heart failure
- B. Black race
- C. Bilateral renal artery stenosis (Correct Answer)
- D. Chronic obstructive pulmonary disease
- E. Gout
Direct renin inhibitors Explanation: ***Bilateral renal artery stenosis***
- The patient's developing **cough** after starting a new antihypertensive suggests he was likely prescribed an **ACE inhibitor**.
- **Bilateral renal artery stenosis** is a strong contraindication for ACE inhibitors due to the risk of precipitating **acute kidney injury**, as these medications rely on efferent arteriolar vasodilation to maintain renal perfusion when there's reduced afferent flow.
*Congestive heart failure*
- **ACE inhibitors** are often a **first-line treatment** for heart failure due to their ability to improve cardiac remodeling and reduce mortality.
- They are used to prevent ventricular remodeling and reduce afterload, making this an indication, not a contraindication.
*Black race*
- While ACE inhibitors may be **less effective as monotherapy** in black patients, they are not contraindicated and can be effectively used in combination with other antihypertensives, such as **thiazide diuretics** or **calcium channel blockers**.
- **African Americans** often respond better to calcium channel blockers and diuretics for hypertension but ACE inhibitors are not absolutely contraindicated.
*Chronic obstructive pulmonary disease*
- **ACE inhibitors** are **not contraindicated** in COPD, as they do not affect bronchial smooth muscle tone.
- **Beta-blockers**, not ACE inhibitors, are typically avoided or used with caution in patients with reactive airway diseases like asthma or severe COPD.
*Gout*
- **ACE inhibitors** do not significantly impact **uric acid levels** and are generally safe for use in patients with gout.
- In contrast, **thiazide diuretics** can increase uric acid levels and worsen gout, but this is not the medication indicated by the patient's cough.
Direct renin inhibitors US Medical PG Question 7: A 72-year-old man presents to the outpatient clinic today. He has New York Heart Association class III heart failure. His current medications include captopril 20 mg, furosemide 40 mg, potassium chloride 10 mg twice daily, rosuvastatin 20 mg, and aspirin 81 mg. He reports that he generally feels well and has not had any recent worsening of his symptoms. His blood pressure is 132/85 mm Hg and heart rate is 84/min. Physical examination is unremarkable except for trace pitting edema of the bilateral lower extremities. What other medication should be added to his heart failure regimen?
- A. Losartan
- B. Metoprolol tartrate
- C. Isosorbide dinitrate/hydralazine
- D. Metoprolol succinate (Correct Answer)
- E. Digoxin
Direct renin inhibitors Explanation: ***Metoprolol succinate***
- Current guidelines recommend adding a **beta-blocker** (specifically metoprolol succinate, carvedilol, or bisoprolol) as part of guideline-directed medical therapy (GDMT) for **NYHA class II-IV heart failure with reduced ejection fraction (HFrEF)**.
- This patient is already on an **ACE inhibitor and diuretic** but is missing a **beta-blocker**, which is a cornerstone of HFrEF therapy.
- Beta-blockers **reduce mortality and morbidity** in HFrEF by counteracting chronic sympathetic activation, improving cardiac remodeling, and reducing heart rate.
- Metoprolol succinate is the **long-acting formulation** preferred for chronic heart failure management.
***Incorrect Option: Losartan***
- The patient is already on an **ACE inhibitor (captopril)**, which acts on the renin-angiotensin-aldosterone system.
- Adding an **ARB (angiotensin receptor blocker)** like losartan to an ACE inhibitor is generally not recommended due to increased risk of hyperkalemia, hypotension, and renal dysfunction without significant additional benefit.
- ARBs are typically used as an alternative when patients cannot tolerate ACE inhibitors (e.g., due to cough or angioedema).
***Incorrect Option: Metoprolol tartrate***
- While metoprolol tartrate is a beta-blocker, it is a **short-acting formulation** typically used for acute conditions like hypertension or angina.
- For **chronic heart failure management**, **long-acting beta-blockers** such as metoprolol succinate are preferred due to sustained therapeutic levels, better adherence, and proven mortality benefit in clinical trials.
***Incorrect Option: Isosorbide dinitrate/hydralazine***
- This combination is primarily indicated for **African American patients with NYHA class III-IV HFrEF** who remain symptomatic despite optimal therapy, or as an alternative in patients who cannot tolerate ACE inhibitors/ARBs.
- While the patient has class III heart failure, he is **not yet on a beta-blocker**, which is a more fundamental component of GDMT and should be added first.
- This combination is typically added as a fourth-line agent.
***Incorrect Option: Digoxin***
- Digoxin is considered for patients with **HFrEF who remain symptomatic** despite optimized therapy with ACE inhibitors/ARBs, beta-blockers, and mineralocorticoid receptor antagonists (MRAs).
- It primarily helps **improve symptoms and reduce hospitalizations** but does not reduce mortality.
- Since this patient is not yet on a beta-blocker, adding the beta-blocker takes priority.
Direct renin inhibitors US Medical PG Question 8: A 70-year-old man presents to his primary care physician for a general checkup. He states that he has been doing well and taking his medications as prescribed. He recently started a new diet and supplement to improve his health and has started exercising. The patient has a past medical history of diabetes, a myocardial infarction, and hypertension. He denies any shortness of breath at rest or with exertion. An ECG is performed and is within normal limits. Laboratory values are ordered as seen below.
Serum:
Na+: 139 mEq/L
Cl-: 100 mEq/L
K+: 6.7 mEq/L
HCO3-: 25 mEq/L
Glucose: 133 mg/dL
Ca2+: 10.2 mg/dL
Which of the following is the most likely cause of this patient's presentation?
- A. Medication (Correct Answer)
- B. Acute renal failure
- C. Hemolysis
- D. Dietary changes
- E. Rhabdomyolysis
Direct renin inhibitors Explanation: ***Medication***
- The patient's **hyperkalemia** (K+ 6.7 mEq/L) despite feeling well, suggests a common side effect of medications, particularly those used for his pre-existing conditions like **hypertension** (**ACE inhibitors**, **ARBs**, **spironolactone**) and **diabetes**.
- Medications are a frequent cause of asymptomatic electrolyte abnormalities, and given his complex medical history and the absence of acute symptoms, this is the most likely culprit.
*Acute renal failure*
- While acute renal failure can cause **hyperkalemia**, it typically presents with other symptoms such as **oliguria**, **fluid retention**, or other signs of organ dysfunction, which are not described.
- The patient is reported to be "doing well" without **shortness of breath** or other acute complaints, making acute renal failure less likely as the primary cause of isolated hyperkalemia.
*Hemolysis*
- **Hemolysis** can release intracellular potassium, leading to **pseudohyperkalemia**, but it would typically be suspected in cases of **blood draw errors** or conditions causing red blood cell breakdown, none of which are indicated.
- The patient's presentation does not include any signs or symptoms suggestive of red cell destruction.
*Dietary changes*
- While an extremely **high-potassium diet** or certain **supplements** could contribute to hyperkalemia, it is less common for dietary changes alone to cause such a significant elevation in a patient with normal organ function.
- Given his medical history, medication-induced hyperkalemia is a more direct and common explanation.
*Rhabdomyolysis*
- **Rhabdomyolysis** involves the breakdown of muscle tissue, releasing potassium and other intracellular contents, but it is usually associated with significant **muscle pain**, **weakness**, and elevated **creatine kinase**.
- The patient denies these symptoms and has no other indicators pointing towards severe muscle injury.
Direct renin inhibitors US Medical PG Question 9: A 58-year-old man presents for a follow-up appointment. He recently was found to have a history of stage 2 chronic kidney disease secondary to benign prostatic hyperplasia leading to urinary tract obstruction. He has no other medical conditions. His father died at age 86 from a stroke, and his mother lives in an assisted living facility. He smokes a pack of cigarettes a day and occasionally drinks alcohol. His vital signs include: blood pressure 130/75 mm Hg, pulse 75/min, respiratory rate 17/min, and temperature 36.5°C (97.7°F). His physical examination is unremarkable. A 24-hour urine specimen reveals the following findings:
Specific gravity 1,050
pH 5.6
Nitrites (-)
Glucose (-)
Proteins 250 mg/24hrs
Which of the following should be prescribed to this patient to decrease his cardiovascular risk?
- A. Enalapril (Correct Answer)
- B. Ezetimibe
- C. Amlodipine
- D. Carvedilol
- E. Aspirin
Direct renin inhibitors Explanation: ***Enalapril***
- **Enalapril**, an ACE inhibitor, is indicated for patients with **chronic kidney disease** and **proteinuria** to reduce cardiovascular risk and slow kidney disease progression.
- The patient has stage 2 CKD and **250 mg/24hrs of protein in urine**, which, when coupled with hypertension, makes ACE inhibitors the preferred choice to mitigate cardiovascular risk.
*Ezetimibe*
- **Ezetimibe** is a **cholesterol absorption inhibitor** used to lower LDL-C, but there is no information in the vignette to suggest hyperlipidemia.
- It is an inappropriate choice without evidence of dyslipidemia or a strong indication for lipid-lowering therapy.
*Amlodipine*
- **Amlodipine** is a **calcium channel blocker** used to treat hypertension but does not provide specific renal-protective benefits in patients with proteinuria.
- It would be a consideration for blood pressure control if an ACE inhibitor were contraindicated or insufficient.
*Carvedilol*
- **Carvedilol** is a **beta-blocker** used for hypertension, heart failure, and post-MI, but there is no indication for its use here.
- It is not the first-line agent for cardiovascular risk reduction in patients with chronic kidney disease and proteinuria without other specific cardiac indications.
*Aspirin*
- **Aspirin** is used for primary or secondary prevention of cardiovascular events due to its **antiplatelet effects**. However, in the absence of established cardiovascular disease, its use for primary prevention in CKD patients needs careful consideration of bleeding risk.
- While patients with CKD are at higher cardiovascular risk, an ACE inhibitor addresses both the hypertension and proteinuria, which directly contribute to cardiovascular and kidney disease progression in this patient.
Direct renin inhibitors US Medical PG Question 10: A 63-year-old African American man presents to the emergency department with edema over his face and difficulty breathing. Past medical history is significant for hypertension and dyslipidemia. He recently began lisinopril and atorvastatin several weeks ago. His father died at 80 years from complications of a stroke and his mother lives in a nursing home. His blood pressure is 135/92 mm Hg, the heart rate is 101/min, the respiratory rate is 21/min, the temperature is 37.0°C (98.6°F). Clinical pathology results suggest a normal C1 esterase inhibitor level. Of the following options, which is the most likely diagnosis?
- A. Contact dermatitis
- B. Facial lymphedema
- C. Drug-induced angioedema (Correct Answer)
- D. Scleredema
- E. Erysipelas
Direct renin inhibitors Explanation: ***Drug-induced angioedema***
- The patient's recent initiation of **lisinopril**, an **ACE inhibitor**, is a strong risk factor for developing **angioedema**, particularly in African American individuals.
- The presentation of **facial edema** and **difficulty breathing** without signs of urticaria or pruritus, and normal C1 esterase inhibitor levels, is consistent with ACE inhibitor-induced bradykinin-mediated angioedema.
*Contact dermatitis*
- This condition typically presents with **pruritus**, **erythema**, and sometimes **vesicles** or **bullae**, which are not described in this patient's symptoms.
- It is usually localized to the area of contact with an allergen or irritant and would be unlikely to cause such acute respiratory distress without other prominent skin manifestations.
*Facial lymphedema*
- **Lymphedema** generally develops **gradually** and is characterized by chronic, non-pitting edema due to impaired lymphatic drainage.
- It would not typically present with acute onset **difficulty breathing** as a primary symptom.
*Scleredema*
- **Scleredema** is a rare connective tissue disorder characterized by diffuse, non-pitting hardening and thickening of the skin, often on the back, neck, and face.
- It is a **chronic condition** and does not typically cause acute onset of facial edema and respiratory distress.
*Erysipelas*
- **Erysipelas** is a superficial skin infection characterized by a well-demarcated, erythematous, warm, and tender plaque, often accompanied by fever and systemic symptoms.
- The patient's presentation of painless facial edema and difficulty breathing without clear signs of infection makes erysipelas less likely.
More Direct renin inhibitors US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
